BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11100383)

  • 41. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
    Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
    Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
    Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
    Morimoto Y; Tanaka Y; Ito T; Nakahara M; Nakaba H; Nishida T; Fujikawa M; Ito T; Yamamoto S; Kitagawa T
    J Hepatobiliary Pancreat Surg; 2003; 10(6):432-40. PubMed ID: 14714164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of long-term survival in pN3 gastric cancer patients.
    Kim J; Cheong JH; Hyung WJ; Shen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Oct; 88(1):9-13. PubMed ID: 15384089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of long-term follow-up of early gastric cancer.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 Mar; 13(3):363-9. PubMed ID: 16485155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of peritoneal washing cytology in patients with potentially resectable gastric cancer.
    Nakagohri T; Yoneyama Y; Kinoshita T; Konishi M; Inoue K; Takahashi S
    Hepatogastroenterology; 2008; 55(86-87):1913-5. PubMed ID: 19102421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic strategy for patients with pN0 gastric carcinoma.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
    Wu CY; Chen JT; Chen GH; Yeh HZ
    Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
    Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
    Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment for advanced gastric cancer.
    Maekawa S; Saku M; Maehara Y; Sadanaga N; Ikejiri K; Anai H; Kuwano H; Sugimachi K
    Hepatogastroenterology; 1996; 43(7):178-86. PubMed ID: 8682459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of age on prognosis in patients with gastric cancer.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Tatebe S; Tsujitani S; Ikeguchi M
    ANZ J Surg; 2006 Jun; 76(6):458-61. PubMed ID: 16768768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term results of surgery for early gastric cancer.
    Popiela T; Kulig J; Kolodziejczyk P; Sierzega M;
    Br J Surg; 2002 Aug; 89(8):1035-42. PubMed ID: 12153632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric cancer in the young.
    Lai IR; Lee WJ; Chen CN; Lee PH; Chang KJ; Chang-Yu S; Chen KM
    Hepatogastroenterology; 1997; 44(18):1641-5. PubMed ID: 9427036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperthermia adjunct to surgery in the treatment of scirrhous carcinoma of the stomach].
    Kaibara N; Maeta M; Hamazoe R; Inoue Y; Koga S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1269-72. PubMed ID: 2837987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
    Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
    Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes].
    Li YM; Zhan WH; Han FH; He YL; Peng JS; Cai SR; Ma JP; Zhao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):127-30. PubMed ID: 16555151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
    Lazăr D; Tăban S; Dema A; Cornianu M; Goldiş A; Raţiu I; Sporea I
    Rom J Morphol Embryol; 2009; 50(1):41-50. PubMed ID: 19221644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.